glp 1 trump deal low-cost GLP-1 plan a likely boost for Eli Lilly, Novo Nordisk Trump announces deal to sell
Description
Found Health's website references clinical trial data showing that in a 68-week trial studying Wegovy (semaglutide 2.4 mg), the average weight loss was approximately 15% when paired with diet and exercise changes
That also could potentially undo any metabolic improvements that can go hand-in-hand with weight loss, such as in diabetes and blood pressure
Belani A, Kresovi A, Troskot Dijan M (2021) Glucagon-like peptide-1 receptor agonists in the era of COVID -19: Friend or foe
Hall, A
, Poon, T
Over-exercising can overstress your hormonal system
